In view of the apparent correlation between higher CD300LG levels and a more favorable prognosis in several types of cancer patients, further elucidation of the mechanisms by which CD300LGhigh TAMos enhance TCM cell differentiation may provide opportunities to improve antitumor immunity by taking advantage of the immuno‐remodeling function of TAMos in different cancer types. The gene discussed is CD300LG; the disease is cancer.